Min Jiang

机构：Capital Medical University, Chinese Academy of Sciences, Sichuan University, West China Hospital of Sichuan University, Institute of Microbiology, China Academy of Chinese Medical Sciences, Beijing Shijitan Hospital, University of Chinese Academy of Sciences · ORCID：0000-0003-0954-0612

发表论文 47 篇 · 总被引 2031 次 · h-index 21

代表论文

• Polymeric microneedle-mediated transdermal delivery of melittin for rheumatoid arthritis treatment (2021 · Journal of Controlled Release · 被引 171)
• KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors (2023 · Nature Communications · 被引 89)
• Immune Checkpoint Inhibitors in Cancer Therapy—How to Overcome Drug Resistance? (2022 · Cancers · 被引 83)
• Chimeric antigen receptor T‐cell therapy as a bridge to haematopoietic stem cell transplantation for refractory/relapsed B‐cell acute lymphoblastic leukemia (2019 · British Journal of Haematology · 被引 49)
• PD-1 N58-Glycosylation-Dependent Binding of Monoclonal Antibody Cemiplimab for Immune Checkpoint Therapy (2022 · Frontiers in Immunology · 被引 46)
• Progress in the Application of Immune Checkpoint Inhibitor-Based Immunotherapy for Targeting Different Types of Colorectal Cancer (2021 · Frontiers in Oncology · 被引 45)